A developer of stem cell therapies for neurological disorders is receiving an $8 million grant to advance a treatment for a common type of epilepsy. . . . → Read More: Grant Funds Epilepsy Stem Cell Therapy Trial
|
|||||
       
 |
A study is now enrolling individuals to better understand different types of obesity, as well as genetics and other factors behind various obesity conditions. . . . → Read More: Biobank Study to Assess Obesity Types, Genetics 
A start-up enterprise developing a high-performance genomic screening and detection technology is raising $15 million in early financing. . . . → Read More: High Speed Genetics Tech Start-Up Raises $15M 
A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced. . . . → Read More: AI Drug Company Creating Covid-19 Therapy for Rapid Delivery 
Results from a clinical trial show a microbiome treatment produces healthy gut microbes that reduce recurrences of C. difficile infections. . . . → Read More: Trial Shows Therapy Controls Gut Disorder with Healthy Microbes 
A developer of addiction therapies and virtual reality software company are collaborating on help for veterans suffering from post-traumatic stress disorder. . . . → Read More: Addiction Therapy, VR Companies Partner on Veteran PTSD 
A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases. . . . → Read More: Venture Investor Funds Cell Therapy Targeting Tech 
A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds. . . . → Read More: Precision Antibacterial Company Raises $35M in New Funds 
A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device 
Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years. . . . → Read More: Trial Shows Gene Therapy Results with Sickle Cell Disease |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
